Skip to main content
S&P 5007,722.60+0.60%DOW52,377.57+0.03%NASDAQ26,477.81+1.18%BTC$81,451.00+2.47%ETH$2,368.30+3.01%GOLD$4,063.10-0.28%OIL$101.66+1.76%
Smart Investors Daily
SID Premium
SS

OTC · SSDOY

Shiseido Company, Limited

Consumer Defensive · Household & Personal Products

$23.35

Down-$0.67 (-2.79%)

Updated Oct 28, 2026, 10:26 AM

SID Score

5.7/10

Composite research score

Smart Money

46/100

Neutral

Market cap
5.98B
P/E ratio
-19.71
Dividend yield
0.86%
52-week range
$13.60 – $23.91
Volume
36.04K
Avg. volume
46.37K

Price performance · SSDOY

SSDOY price history

1M range · 0 trading sessions · Daily adjusted prices

SSDOY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SSDOY news

The latest Smart Investors Daily articles mentioning SSDOY.

Stock researchCompany · Overview

SSDOY research

Overview

Company profile and research snapshot.

Company profile

SHISEIDO CO LTD S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 24, 2026

Shiseido (TSE:4911) Stock May Look Pricey On Cash Flow Prospects

Shiseido Company has delivered a sharp share price rebound this year, which puts a bright spotlight on how much cash the business is realistically expected to generate. With that kind of move on the screen, the key issue for you is whether those cash flows support where the stock trades today. The share price is up 60.6% year to date. Anyone buying now is effectively betting that future cash generation can support this higher base. The business depends heavily on converting its beauty and...

Yahoo · Oct 13, 2026

Shiseido Company (TSE:4911) Could Be 27% Overvalued On Biosignal Serum Buzz

Shiseido Company (TSE:4911) is back in focus after being highlighted as a key participant in the fast growing biosignal serums segment, tied to anti aging and personalized skincare demand. Recent attention on biosignal serums comes as Shiseido Company’s share price sits at ¥3,286, with a 1-day share price return of 1.29% and a 90-day gain of 10.10%. This follows a strong year-to-date share price return of 42.28%, while the 5-year total shareholder return declined 52.63%. The figures highlight...

Yahoo · Oct 12, 2026

Global BioSignal Serums Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on Peptides and E-Commerce with Shiseido, Obagi, Revision Skincare and ExoCoBio

Boost ROI through peptide innovation, personalized skincare, e-commerce/DTC expansion, clinical partnerships, local sourcing and cost-efficient formulations.Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "BioSignal Serums Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global biosignal serums market is experiencing strong growth as consumers, dermatology clinics, and medical aesthetic providers increase their use of advanced skincare formulations. The market is pro

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By